NovoCure Ltd (NVCR) stock
NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3027% below fair value
$11.83+0.11 (+0.94%)
Close on Nov 13, 2026Market cap $1.38BP/E –Yield –
NovoCure profit margin
Profit margin (net margin) is net income as a percentage of revenue.
NovoCure's profit margin for the twelve months ending Sep 30, 2026 was -16.8%. For fiscal 2025 it was -20.8%, against -27.9% the year before. The highest annual figure on record is 4.0% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -20.8% | +7.1 |
| FY2024 | Dec 31, 2024 | -27.9% | +12.8 |
| FY2023 | Dec 31, 2023 | -40.6% | −23.4 |
| FY2022 | Dec 31, 2022 | -17.2% | −6.3 |
| FY2021 | Dec 31, 2021 | -10.9% | −14.9 |
| FY2020 | Dec 31, 2020 | 4.0% | +6.1 |
| FY2019 | Dec 31, 2019 | -2.1% | +23.6 |
| FY2018 | Dec 31, 2018 | -25.6% | +9.2 |
| FY2017 | Dec 31, 2017 | -34.8% | +124.2 |
| FY2016 | Dec 31, 2016 | -159.1% | +178.2 |
| FY2015 | Dec 31, 2015 | -337.2% | +183.6 |
| FY2014 | Dec 31, 2014 | -520.9% | +226.0 |
| FY2013 | Dec 31, 2013 | -746.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -5.4% | +16.9 |
| Q2 FY2026 | Jun 30, 2026 | -8.5% | +16.7 |
| Q1 FY2026 | Mar 31, 2026 | -40.9% | −18.7 |
| Q4 FY2025 | Dec 31, 2025 | -14.1% | +26.8 |
| Q3 FY2025 | Sep 30, 2025 | -22.3% | −2.6 |
| Q2 FY2025 | Jun 30, 2025 | -25.3% | −3.1 |
| Q1 FY2025 | Mar 31, 2025 | -22.1% | +5.8 |
| Q4 FY2024 | Dec 31, 2024 | -40.9% | −5.7 |
| Q3 FY2024 | Sep 30, 2024 | -19.7% | +19.2 |
| Q2 FY2024 | Jun 30, 2024 | -22.2% | +23.4 |
| Q1 FY2024 | Mar 31, 2024 | -28.0% | +15.4 |
| Q4 FY2023 | Dec 31, 2023 | -35.2% | −6.1 |
| Q3 FY2023 | Sep 30, 2023 | -38.9% | −18.6 |
| Q2 FY2023 | Jun 30, 2023 | -45.6% | −28.5 |
| Q1 FY2023 | Mar 31, 2023 | -43.4% | −40.0 |
| Q4 FY2022 | Dec 31, 2022 | -29.0% | −9.2 |
| Q3 FY2022 | Sep 30, 2022 | -20.3% | −10.5 |
| Q2 FY2022 | Jun 30, 2022 | -17.0% | −6.1 |
| Q1 FY2022 | Mar 31, 2022 | -3.4% | −0.3 |
| Q4 FY2021 | Dec 31, 2021 | -19.9% | −23.3 |
| Q3 FY2021 | Sep 30, 2021 | -9.8% | −16.8 |
| Q2 FY2021 | Jun 30, 2021 | -11.0% | −12.4 |
| Q1 FY2021 | Mar 31, 2021 | -3.1% | −6.9 |
| Q4 FY2020 | Dec 31, 2020 | 3.4% | −0.9 |
| Q3 FY2020 | Sep 30, 2020 | 7.0% | +4.9 |
| Q2 FY2020 | Jun 30, 2020 | 1.4% | +2.9 |
| Q1 FY2020 | Mar 31, 2020 | 3.9% | +20.5 |
| Q4 FY2019 | Dec 31, 2019 | 4.3% | +26.7 |
| Q3 FY2019 | Sep 30, 2019 | 2.1% | +20.2 |
| Q2 FY2019 | Jun 30, 2019 | -1.5% | +23.7 |
| Q1 FY2019 | Mar 31, 2019 | -16.6% | +23.2 |
| Q4 FY2018 | Dec 31, 2018 | -22.4% | −2.0 |
| Q3 FY2018 | Sep 30, 2018 | -18.1% | +4.9 |
| Q2 FY2018 | Jun 30, 2018 | -25.2% | +30.0 |
| Q1 FY2018 | Mar 31, 2018 | -39.8% | +12.0 |
| Q4 FY2017 | Dec 31, 2017 | -20.4% | +52.9 |
| Q3 FY2017 | Sep 30, 2017 | -22.9% | – |
| Q2 FY2017 | Jun 30, 2017 | -55.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -51.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -73.3% | – |
See a number that looks wrong?